Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice
- Mu-Huo Ji†1,
- Li-Li Qiu†1,
- Hui Tang1,
- Ling-Sha Ju1,
- Xiao-Ru Sun1,
- Hui Zhang1,
- Min Jia1,
- Zhi-Yi Zuo2,
- Jin-Chun Shen1Email author and
- Jian-Jun Yang1Email author
© Ji et al. 2015
Received: 3 August 2015
Accepted: 17 September 2015
Published: 29 September 2015
Sepsis-associated encephalopathy (SAE) is a diffuse brain dysfunction caused by many pathological events, including neuroinflammation and oxidative stress damage. Increasing evidence suggests that parvalbumin (PV) interneurons play a key role in the cognitive process, whereas the dysfunction of these interneurons has been implicated in a number of major psychiatric disorders. Here, we aimed to investigate whether enhanced inflammation and oxidative stress-mediated PV interneuron phenotype loss plays a role in sepsis-induced cognitive impairments.
Male C57BL/6 mice were subjected to cecal ligation and puncture or sham operation. For the interventional study, the animals were chronically treated with a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, apocynin, at 5 mg/kg. The mice were euthanized at the indicated time points, and the brain tissues were harvested for determination of the PV, membrane subunit of NADPH oxidase gp91phox, and markers of oxidative stress (4-hydroxynonenal and malondialdehyde) and inflammation (tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, and IL-10). A separate cohort of animals was used to evaluate the behavioral alterations by the open field and fear conditioning tests. Primary hippocampal neuronal cultures were used to investigate the mechanisms underlying the dysfunction of PV interneurons.
Sepsis resulted in cognitive impairments, which was accompanied by selective phenotype loss of PV interneurons and increased gp91phox, 4-hydroxynonenal, malondialdehyde, IL-1β, and IL-6 expressions. Notably, these abnormalities could be rescued by apocynin treatment.
Selective phenotype loss of PV interneurons, as a result of NADPH oxidase 2 (Nox2) activation, might partly contribute to cognitive impairments in a mouse model of SAE.
KeywordsParvalbumin interneurons Cognition Sepsis NADPH oxidase Oxidative stress
Sepsis-associated encephalopathy (SAE) is a common brain dysfunction induced by systemic responses to infection, which often presents serious long-term cognitive impairments that can affect up to 70 % of patients with severe sepsis, leading to poor quality of life and increased mortality [1–5]. Several potential mechanisms, including oxidative stress, inflammation, neurotransmission disturbance, mitochondrial dysfunction, and cell death, have been proposed to be involved in the pathogenesis of SAE , but how these pathological factors lead to cognitive impairments remains largely to be elucidated.
Parvalbumin (PV) interneurons are a subset of inhibitory GABAergic neurons that control the excitability of post-synaptic pyramidal neurons . These interneurons are critically involved in the generation of gamma oscillations, which facilitates the information processing during sensory perception and cognitive tasks [6–9]. By contrast, dysfunction or phenotype loss of PV interneurons (represented by decreased expression of GABA-related genes such as the 67-kDa isoform of glutamate decarboxylase or PV) has been implicated in cognitive deficits associated with a number of major psychiatric disorders, including schizophrenia , Alzheimer’s disease , and depression . Although the precise mechanism underlying dysfunction of PV interneurons remains unknown, oxidative stress has been realized to be a contributing factor because of the high metabolic requirements of these interneurons [13–15]. In particular, superoxide overproduction as a result of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (Nox2) activation leads to the reduced expression of GABAergic markers and consequent loss of inhibitory capacity of PV interneurons [16, 17]. Presently unknown, however, is whether Nox2 activation-induced PV interneuron dysfunction is involved in the sepsis-induced cognitive impairments.
Herein, we investigated whether the expression of PV in the prefrontal cortex (PFC) and hippocampus is altered after sepsis development and whether gp91phox activation, the catalytic subunit of Nox2, contributes to these changes in a mouse model of SAE.
Materials and methods
Three hundred and sixty male C57BL/6 mice (3–4 months, 25–32 g) were purchased from the Animal Center of Jinling Hospital, Nanjing, China. The study protocol was approved by the Ethics Committee of Jinling Hospital, Nanjing University, and all procedures were performed in accordance with the Guideline for the Care and Use of Laboratory Animals from the National Institutes of Health, USA. The animals were housed under a 12-h light/dark cycle in a temperature-controlled room at 24 ± 1 °C with free access to food and water.
Apocynin (Sigma, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (Sigma, St. Louis, MO, USA) and then diluted in normal saline. For the dose-response study, apocynin at 2.5, 5, or 10 mg/kg was intraperitoneally injected immediately and once daily for 10 consecutive days after the operation to determine the optimal dose for the therapy of sepsis-induced cognitive impairments. For the sham groups, the same volume of dimethyl sulfoxide diluted into normal saline was intraperitoneally injected.
Behavioral and cognitive tests
All behavioral tests were performed at 2:00–5:00 p.m. in a sound-isolated room by the instrument of XR-XZ301 (Xinruan Corporation, Shanghai Soft maze Information Technology Co. Ltd., China). All behavioral data were recorded by the same investigator who was blinded to the animal grouping as described in our previous studies [19, 20].
Open field test
The mice were gently placed in the center of a white plastic chamber (40 cm × 40 cm × 40 cm) for 5 min while exploratory behaviors were automatically recorded by a video tracking system. The total distance traveled and the time spent in the center of the open field were recorded. At the end of each test, the surface of the arena was cleaned thoroughly with 75 % alcohol to avoid the presence of olfactory cues.
Fear conditioning test
To measure the associative memory, we employed the fear conditioning paradigm (26-cm long × 18-cm wide × 22-cm high). Briefly, the training consisted of a single exposure to a novel context for 3 min, followed by a tone for 30 s (65 dB, 3 kHz) and a single electric foot shock (3 s, 0.75 mA). The contextual fear conditioning test was performed 24 h later by placing the mice back to the same chamber for 5 min. Two hours after the contextual fear conditioning test, the mice were placed into a chamber that was different in shape, color, and smell from the previous one. The training tone was delivered for 3 min to evaluate the tone fear conditioning. The freezing behavior was defined as the absence of all visible movement of the body except for respiration.
Western blotting analysis
The mice were killed by decapitation, and the brains were removed for determination of the PV, gp91phox, and 4-HNE levels at the indicated time points. Briefly, the brain tissues were homogenized on ice using immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, and 0.5 % Nonidet P-40) plus protease inhibitors (1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepstatin A). The lysates were collected, centrifuged at 10,000×g at 4 °C for 10 min. The supernatant was removed, and protein concentration was determined using the Pierce Bicinchoninic Acid Protein Assay kit (Pierce Technology Co., Iselin, NJ, USA) with bovine serum albumin (BSA) as the standard. Equal amounts of protein were electrophoretically separated on 4–12 % NuPAGE Novex Bis-Tris gradient gels (Invitrogen, NY, USA) and transferred to the polyvinylidene fluoride membranes. After blocking with 5 % non-fat milk for 1 h at room temperature, the membranes were incubated with rabbit anti-PV (1:1000; Abcam, Cambridge, UK), mouse anti-4-HNE (1:500, Abcam), goat anti-gp91phox (1:500; Santa Cruz, Dallas, TX), and mouse anti-GAPDH (1:5000; millipore) overnight at 4 °C, followed by horseradish peroxidase-conjugated secondary antibodies (GE Healthcare, Pittsburgh, PA, USA) for 2 h at room temperature. The protein bands were detected by enhanced chemiluminescence and the quantitation of bands was undertaken using the Image J software (NIH Image, Bethesda, MD, USA).
Enzyme-linked immunosorbent assay
The mice were killed by decapitation, and the brain tissues were isolated and washed with ice-cold physiological saline to remove the surface blood. The PFC and hippocampus were then separated, weighed, and placed in a homogenizer. The tissue was homogenized with 1-ml ice-cold physiological saline per 100-mg brain tissue. Hypothermal centrifugation was performed at 10,000×g for 10 min, and the supernatant was obtained. Standard curves for all cytokines (in duplicates) were generated using the reference cytokine concentrations supplied. Tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, and IL-10 were quantified using specific enzyme-linked immunosorbent assay (ELISA) kits for rats according to the manufacturers’ instructions (R&D Systems, Minneapolis, MN, USA).
Measurement of malondialdehyde and superoxide dismutase (SOD)
The level of malondialdehyde (MDA) in the PFC and hippocampus, a measure of lipid peroxidation, was assayed in the form of thiobarbituric acid-reactive substances (Jiancheng Bioengineering Institute, Nanjing, China) as described in our previous study . The superoxide dismutase (SOD) activity in the PFC and hippocampus was determined using a SOD assay kit (Jiancheng Bioengineering Institute, Nanjing, China) as we previously described . The MDA level is expressed as nmol/mg protein, and the SOD activity is expressed as U/mg protein.
The mice were deeply anesthetized with 2 % sodium pentobarbital in saline (60 mg/kg, intraperitoneally; Sigma Chemical Co., St. Louis, MO) and transcardially perfused with physiological saline, followed by 4 % paraformaldehyde in phosphate-buffered saline (PBS; pH = 7.4). The brains were immediately removed, postfixed in the same 4 % paraformaldehyde for 2 h, and dehydrated in 30 % sucrose at 4 °C overnight. They were embedded in optimum cutting compound and cut into 10-μm-thick coronal sections on freezing microtome. The brain sections were mounted on glass slides. The sections were blocked with 1 % BSA for 1 h at room temperature and followed by incubating them with the following primary antibodies: rabbit anti-PV (1:600; Abcam), mouse anti-PV (1:600; Millipore), goat anti-gp91phox (1:200; Santa Cruz), and mouse anti-8-OH-dG (1:200; Santa Cruz) in 1 % BSA at 4 °C overnight. After three washes with PBS, the sections were incubated with the secondary antibodies, goat anti-rabbit IgG-flurescein isothiocyanate (FITC), or Cy3 (1:300; Santa Cruz), goat anti-mouse IgG-FITC or Cy3 (1:600; Bioworld, San Diego, USA), and donkey anti-goat IgG-Cy3 (1:800; Abcam) for 1 h at room temperature. After washing out the secondary antibody, the sections were incubated with 4′,6-diamidino-2-phenylindole for nuclear staining. Fluorescent images were captured by a confocal microscope (Olympus, Japan).
Neuronal cultures and immunostaining
Primary hippocampal neuronal cultures were prepared according to a previously described protocol with minor modifications [22, 23]. The brains were removed quickly from C57BL/6 mice within 24 h after birth, and the hippocampus was dissected and mechanically disaggregated by gentle trituration using a Pasteur pipette. Dissociated cells were cultured in the neurobasal medium supplemented with 50 × B27, 100 × L-glutamine (200 mM), and 100 × penicillin/streptomycin. The cells were plated at a density of ~1.4 × 104 cells per cm2 in polylysine-coated 15-mm multi-well plates. Every 3 days, half of the medium was replaced by freshly prepared medium. Fourteen days after culturing, apocynin (0.5 mM) was added alone or in combination with lipopolysaccharide (LPS) (1 μg/ml). Twenty-four hours later, the neurons in culture were fixed.
For the immunostaining, dissociated neurons were fixed for 10 min at room temperature with 4 % paraformaldehyde/4 % sucrose mixture in PBS that was warmed to 37 °C in advance. The neurons were then permeabilized by 0.1 % Triton X-100 solution in PBS for 10 min at room temperature and washed gently. The neurons were blocked by 1 % BSA in PBS for 1 h at room temperature and incubated with the following primary antibodies: rabbit anti-PV (1:600; Abcam), goat anti-gp91phox (1:200; Santa Cruz), and mouse anti-PSD95 (1:200; Millipore) diluted in 1 % BSA at 4 °C overnight. After three washes with PBS, the neurons were incubated with the secondary antibodies, goat anti-rabbit IgG-FITC (1:300; Santa Cruz), goat anti-mouse IgG-Cy3 (1:600; Bioworld), and donkey anti-goat IgG-Cy3 (1:800; Abcam) for 1 h at room temperature. After washing out the secondary antibody, the neurons were incubated with 4′,6-diamidino-2-phenylindole for nuclear staining. Fluorescent images were obtained by confocal scanning microscopy (Leica, TCS SP2, Germany). For a given sample, 5–10 images, taken at 1 μm intervals, were collapsed to generate a projected image. The PSD-95 puncta number was measured by the Image J (NIH).
Statistical analyses were performed by the Statistical Product for Social Sciences (SPSS; version 16.0, IL, USA). Data are presented as mean ± SEM. Distribution of data was analyzed using the Kolmogorov-Smirnov test. Differences among means were assessed by one-way analysis of variance (ANOVA) followed by a Tukey test. The survival rate was plotted by the Kaplan-Meier method and compared by the log-rank test. Bivariate relationship was evaluated by the Pearson correlation coefficients. A p < 0.05 was regarded as statistically significant.
Dose-response of apocynin on fear conditioning test and effects of apocynin treatment on the survival rate of sepsis mice
As indicated in Fig. 1b, the dose-response study of apocynin showed that 5 mg/kg was the optimal dose effective in increasing the freezing behavior. Thus, an apocynin dose of 5 mg/kg was used in our subsequent experiments. In addition, apocynin treatment did not affect the survival rate of sepsis mice (Fig. 1c).
Sepsis-induced cognitive impairments were rescued by apocynin treatment
Sepsis-induced inflammation and oxidative stress in the brain were rescued by apocynin treatment
Sepsis-induced selective PV interneuron phenotype loss was associated with gp91phox activation
Sepsis induced a progressive decrease in PV level from day 3 to day 14. PV level was significantly decreased while gp91phox expression was increased in the hippocampus at day 14 but not day 30 in the CLP + vehicle group when compared with the sham groups. However, apocynin treatment reversed these abnormities after sepsis development [14 days: one-way ANOVA; PFC (PV): F (3, 20) = 0.873, P = 0.471; hippocampus (PV): F (3, 20) = 14.661, P < 0.01]; [14 days: one-way ANOVA; PFC (gp91phox): F (3, 20) = 0.782, P = 0.518; hippocampus (gp91phox): F (3, 20) = 5.585, P = 0.01; Fig. 5c, e]; [30 days: one-way ANOVA; PFC (PV): F (3, 20) = 0.104, P = 0.957; hippocampus (PV): F (3, 20) = 0.019, P = 0.996]; [30 days: one-way ANOVA; PFC (gp91phox): F (3, 20) = 0.022, P = 0.996; hippocampus (gp91phox): F (3, 20) = 0.124, P = 0.945; Fig. 5d, f]. Furthermore, linear regression analysis showed that PV levels were negatively correlated with the expressions of gp91phox (r = −0.7193, p < 0.0001; Fig. 7b).
Sepsis resulted in decreased post-synaptic density protein 95 (PSD-95) puncta numbers in the PV interneurons
Our results confirmed previous finding that sepsis induced gradual behavioral deficits during follow-up , suggesting CLP-induced cognitive impairments are time dependent. More importantly, we demonstrated that sepsis-induced cognitive impairments co-occurred with hippocampal PV interneuron phenotype loss. However, chronic treatment with apocynin, a NADPH inhibitor and reactive oxygen species (ROS) scavenger, rescued these abnormities. These results demonstrated a critical role of PV interneurons in sepsis-induced brain dysfunction.
The pathogenesis of sepsis-induced cognitive impairments is not completely understood. Recent studies implicate the involvement of oxidative stress and neuroinflammation . An extensive body of evidence indicates that sepsis is associated with increased ROS levels, depletion of antioxidants, and accumulation of markers of oxidative stress, which is intimately linked to a variety of pathophysiological processes, such as enhanced inflammatory responses, mitochondrial dysfunction, and hypoactive N-methyl-D-aspartate receptors [5, 18]. Our results also showed that brain oxidative damage and inflammation were critically involved in the development of cognitive impairments after sepsis development, whereas treatment with apocynin abolished the increases in brain oxidative stress and inflammation markers, and ultimately attenuated the cognitive impairments in the sepsis survivors. However, the mechanisms by which these pathological events lead to sepsis-induced cognitive impairments remain unclear.
PV interneurons comprise about 40–50 % of the total GABAergic population, which regulate the activity of neural networks through perisomatic inhibition onto the pyramidal cells . Synchronous activity of the PV interneurons generates gamma oscillations (30–80 Hz), which is important for cognition, learning, and memory . By contrast, PV interneuron abnormities have been proposed to play a causal role in the development of cognition impairments associated with major psychiatric disorders . Here, we reported hippocampal PV interneuron phenotype loss co-occurred with the cognitive impairments during sepsis development. This selective loss of PV interneuron phenotype might be explained by the notion that the hippocampus is vulnerable to inflammation than the PFC. Notably, these abnormalities were precluded in the mice treated with apocynin, providing evidence that PV interneuron phenotype loss and cognitive impairments may be causally linked.
Although the cause of PV interneuron dysfunction in sepsis is not yet understood, PV interneurons have been proposed to be vulnerable to oxidative stress [15–17]. Mitochondria is considered to be the major sources of intracellular ROS, but accumulating evidence suggests that various subunits of NADPH oxidase in the plasma membrane are highly expressed in cortical neurons and can also generate ROS . Activation of NADPH oxidase leads to the generation of the superoxide ion, a ROS that can be converted to the highly reactive hydroxyl radical and to peroxynitrite, a highly damaging reactive nitrogen species [25, 26]. The NADPH oxidase complex is composed of two membrane-bound subunits (gp91phox and p22phox) and four cytoplasmic subunits (p40phox, p47phox, p67phox, and the small G-protein Rac) [27, 28]. Specifically, Nox2-derived ROS production plays a critical role in GABAergic interneuron dysfunction after subchronic ketamine exposure in mice . In the present study, treating animals with apocynin reduced the oxidative stress and prevented the loss of PV immunoreactivity induced by sepsis. Because of the tight link between oxidative stress and inflammation, it is not surprising that pro-inflammatory molecules affect the function of PV interneurons. This notion is supported by the findings that IL-6 mediates ketamine-induced up-regulation of Nox2 and subsequent deficits of PV interneurons , while a nonsteroidal anti-inflammatory drug treatment prevents PV interneuron dysfunction following maternal separation .
To further test the hypothesis that Nox2 activation specifically in the PV interneurons contributes to oxidative stress and subsequent PV interneuron phenotype loss, we performed double-immunofluorescent labeling for PV and gp91phox immunoreactivity. Our data showed that Nox2 was mainly expressed in the PV interneurons, and there was an inverse relationship between PV and Nox2 expressions, suggesting that reduced PV level is associated with elevated oxidative stress in the PV interneurons. Our results are supported by previous study demonstrating that Nox2 up-regulation appears to be responsible for the prolonged oxidative insult on GABAergic neurons . On the other hand, it has been reported that Nox2 is required for glial cell activation and emphasizes the critical role of oxidative damage and Nox2-derived ROS as central factors contributing to sepsis-induced cognitive impairments . Here, we provide additional evidence that Nox2 activation specifically in the PV interneurons at least in part plays an important role in sepsis-induced PV interneuron phenotype loss and subsequent cognitive impairments. However, our data did not exclude the contribution of ROS from other regions such as mitochondria.
The cerebral cortex is comprised of both excitatory (glutamatergic) neurons and inhibitory (GABAergic) interneurons that work together to maintain the balance between inhibition and excitation that is necessary for the normal functioning of the cortex . The excitability of PV interneurons relies on the summation of excitatory and inhibitory signals, which in turn is regulated by the number of excitatory and inhibitory synapses on them . It has been suggested that disrupted excitatory synapse maturation in the GABAergic interneurons is associated with neuropsychiatric disorders such as schizophrenia . To investigate whether the activity of PV interneurons is changed after sepsis development, we examined PSD-95 and revealed that sepsis significantly reduced the number of PSD-95 puncta in the PV interneurons. Intriguingly, apocynin treatment was able to rescue the decreased PSD-95 puncta number. These findings suggest that maintaining the balance between excitation and inhibition is important for the homeostatic control of normal brain function and behaviors.
There are few limitations in our study protocol. For example, we only performed the open field and fear conditioning tests to reflect some of the behavioral alternations after sepsis development. Therefore, future studies are needed to assess other behavioral changes caused by sepsis, including the spatial working memory. Secondly, sepsis induced the amygdala-dependent memory impairments in the present study, thus the role of PV interneurons in the amygdala deserves great research interests.
In conclusion, our study demonstrated that Nox2 activation, at least in part, plays a key role in sepsis-induced PV interneuron phenotype loss and subsequent cognitive impairments. Hence, identifying viable therapeutic strategies to tackle on oxidative stress and neuroinflammation and the consequent PV interneuron disturbances may provide a therapeutic strategy for SAE.
This study was supported by the grants from the National Natural Science Foundation of China (grant nos. 81271216, 81300946, 81471105).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787–94.PubMed CentralView ArticlePubMedGoogle Scholar
- Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38:1513–20.PubMed CentralView ArticlePubMedGoogle Scholar
- Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60:1070–7.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang LN, Ai YH, Gong H, Guo QL, Huang L, Liu ZY, et al. Expression and role of neuroglobin in rats with sepsis-associated encephalopathy. Crit Care Med. 2014;42:e12–21.View ArticlePubMedGoogle Scholar
- Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8:557–66.View ArticlePubMedGoogle Scholar
- Hu H, Gan J, Jonas P. Interneurons. Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263.View ArticlePubMedGoogle Scholar
- Antonucci F, Alpár A, Kacza J, Caleo M, Verderio C, Giani A, et al. Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks. J Neurosci. 2012;32:1989–2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A. 2010;107:1211–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459:698–702.PubMed CentralView ArticlePubMedGoogle Scholar
- Del Pino I, García-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martínez de Lagrán M, et al. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. 2013;79:1152–68.View ArticlePubMedGoogle Scholar
- Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708–21.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou Z, Zhang G, Li X, Liu X, Wang N, Qiu L, et al. Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration. Mol Neurobiol. 2015;51:808–19.View ArticlePubMedGoogle Scholar
- Lucas EK, Markwardt SJ, Gupta S, Meador-Woodruff JH, Lin JD, Overstreet-Wadiche L, et al. Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha. J Neurosci. 2010;30:7227–35.PubMed CentralView ArticlePubMedGoogle Scholar
- Jiang Z, Rompala GR, Zhang S, Cowell RM, Nakazawa K. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol Psychiatry. 2013;73:1024–34.PubMed CentralView ArticlePubMedGoogle Scholar
- Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270–82.PubMed CentralView ArticlePubMedGoogle Scholar
- Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, et al. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry. 2009;66:384–92.View ArticlePubMedGoogle Scholar
- Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V, et al. The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci. 2010;30:11317–25.View ArticlePubMedGoogle Scholar
- Wu J, Dong L, Zhang M, Jia M, Zhang G, Qiu L, et al. Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy. Neurochem Res. 2013;38:2440–9.View ArticlePubMedGoogle Scholar
- Terrando N, Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, Monaco C, et al. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care. 2010;14:R88.PubMed CentralView ArticlePubMedGoogle Scholar
- Ji M, Dong L, Jia M, Liu W, Zhang M, Ju L, et al. Epigenetic enhancement of brain-derived neurotrophic factor signaling pathway improves cognitive impairments induced by isoflurane exposure in aged rats. Mol Neurobiol. 2014;50:937–44.PubMed CentralView ArticlePubMedGoogle Scholar
- Ji MH, Qiu LL, Yang JJ, Zhang H, Sun XR, Zhu SH, et al. Pre-administration of curcumin prevents neonatal sevoflurane exposure-induced neurobehavioral abnormalities in mice. Neurotoxicology. 2015;46:155–64.View ArticlePubMedGoogle Scholar
- Ting AK, Chen Y, Wen L, Yin DM, Shen C, Tao Y, et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci. 2011;31:15–25.PubMed CentralView ArticlePubMedGoogle Scholar
- Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 2008;28:13957–66.PubMed CentralView ArticlePubMedGoogle Scholar
- Tuon L, Comim CM, Petronilho F, Barichello T, Izquierdo I, Quevedo J, et al. Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med. 2008;34:1724–31.View ArticlePubMedGoogle Scholar
- Hernandes MS, D’Avila JC, Trevelin SC, Reis PA, Kinjo ER, Lopes LR, et al. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinflammation. 2014;11:36.PubMed CentralView ArticlePubMedGoogle Scholar
- Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7.View ArticlePubMedGoogle Scholar
- Seo JS, Park JY, Choi J, Kim TK, Shin JH, Lee JK, et al. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J Neurosci. 2012;32:9690–9.View ArticlePubMedGoogle Scholar
- Bruce-Keller AJ, Gupta S, Knight AG, Beckett TL, McMullen JM, Davis PR, et al. Cognitive impairment in humanized APP × PS1 mice is linked to Aβ (1–42) and NOX activation. Neurobiol Dis. 2011;44:317–26.PubMed CentralView ArticlePubMedGoogle Scholar
- Brenhouse HC, Andersen SL. Nonsteroidal anti-inflammatory treatment prevents delayed effects of early life stress in rats. Biol Psychiatry. 2011;70:434–40.View ArticlePubMedGoogle Scholar
- Keith D, El-Husseini A. Excitation control: balancing PSD-95 function at the synapse. Front Mol Neurosci. 2008;1:4.PubMed CentralView ArticlePubMedGoogle Scholar
- Matta JA, Pelkey KA, Craig MT, Chittajallu R, Jeffries BW, McBain CJ. Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity. Nat Neurosci. 2013;16:1032–41.PubMed CentralView ArticlePubMedGoogle Scholar